These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2133733)

  • 81. Nifedipine and the pressor response to laryngoscopy.
    Puri GD
    Anaesthesia; 1989 Jun; 44(6):520. PubMed ID: 2757163
    [No Abstract]   [Full Text] [Related]  

  • 82. Reply: Echocardiographic mPAP/CO Slope: Limitations and Strengths of a Noninvasive Tool for Assessing Exercise Pulmonary Hemodynamics.
    Gargani L; Pugliese NR; Mazzola M; Naeije R; Bossone E
    J Am Coll Cardiol; 2024 Apr; 83(14):e143-e144. PubMed ID: 38569770
    [No Abstract]   [Full Text] [Related]  

  • 83. Pulmonary hemodynamic and tidal volume changes during exercise in heart failure.
    Agostoni P; Guazzi M; Doria E; Marenzi G
    Ital Heart J; 2002 Feb; 3(2):104-8. PubMed ID: 11926007
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Hemodynamic effects of nisoldipine in chronic congestive heart failure.
    Vogt A; Kreuzer H
    Arzneimittelforschung; 1983; 33(6):877-9. PubMed ID: 6684444
    [TBL] [Abstract][Full Text] [Related]  

  • 85. [Effects of sublingual nifedipine on hemodynamic and metabolic responses to exercise (Ergometer, 25W, 5 min.) in patients with severe congestive heart failure].
    Morimoto Y; Makino M; Umino M; Nagano K; Kakuta Y; Nakano T; Konishi T; Takezawa H
    Kokyu To Junkan; 1987 Jan; 35(1):71-5. PubMed ID: 3563134
    [No Abstract]   [Full Text] [Related]  

  • 86. [The effects of sublingual nifedipine on isometric stress in patients with severe aortic insufficiency. An acute hemodynamic study].
    Mangieri E; Tanzilli G; Acri A; Mangiaracina F; Ferri FM; Mastroianni MA; Nardi M; Pignatelli A; Abbolito S; Missiroli B
    Cardiologia; 1994 Aug; 39(8):577-83. PubMed ID: 7805073
    [TBL] [Abstract][Full Text] [Related]  

  • 87. [Hemodynamic responses to sublingual nifedipine during exercise and recovery in congestive heart failure].
    Yamagata T; Okamoto M; Hashimoto M; Amioka H; Nakagawa H; Morichika N; Kawagoe T; Tsuchioka Y; Matsuura H; Kajiyama G
    J Cardiol; 1990; 20(4):991-9. PubMed ID: 2133733
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Sublingual nifedipine: the continuing controversy.
    Oliver S
    Aust Crit Care; 1994 Jun; 7(2):12-4. PubMed ID: 8061479
    [TBL] [Abstract][Full Text] [Related]  

  • 89.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 90.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 91.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 92.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 93.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 94.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 95.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 5.